$1,800,000
Laboratorio di test estetici e farmaceutici
United States | Pharma | L#20240686

Highly reputed testing lab with over a decade in operation. Specializes in pharmaceutical and beauty product development and testing, serving clients in the Northeast. Their comprehensive services include product development, form ...

$1,800,000
TBD
TBA
United States | Pharma | L#20240619

Biotech business with an excellent safety record of more than 2500 clinical treatments. Company designs, manufactures, and markets affinity blood filtration products. A new and highly innovative hemofiltration device that uses pat ...

TBA
TBD
$1,050,000,000$87,500,000/EBITDA
India | Pharma | L#20240605

The Indian pharmaceutical industry has emerged as a global player in the past few decades, becoming one of the largest producers of generic drugs worldwide. The business of Indian pharmaceuticals has witnessed exponential ...

$1,050,000,000$87,500,000/EBITDA
$87,500,000
$45,000,000$6,279,944/EBITDA
Jordan | Pharma | L#20230509

This Pharmaceutical Manufacturing Company was founded around 40-Year-Old in Amman, Jordan. It holds the regional benchmark in innovation with more than 70 patents. As direct result of this innovation, operations were diversifie ...

$45,000,000$6,279,944/EBITDA
$6,279,944
$40,000,000$3,000,000/EBITDA

The company was founded in the district Punjab India, 1982 with a purpose of manufacturing Active Pharmaceutical Ingredients. The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the ...

$40,000,000$3,000,000/EBITDA
$3,000,000
$11,500,000$450,000/EBITDA

This company has been in the Colombian market for 19 years, it owns the approved INVIMA registrations. There is a serious conversations to expand market to Guatemala and 5 more countries in Central America with one big distribu ...

$11,500,000$450,000/EBITDA
$450,000
$12,000,000TBA/EBITDA
制药

This company for sale is a healthcare company based in Bangalore, India. The business is involved in the manufacturing and supply of medicines and nutritional supplements to people across the globe (Quality standards as specified ...

$12,000,000TBA/EBITDA
TBA
property

Beauty and Pharmaceutical Testing Lab

EBITDA

TBD

Gross

$1,700,000

Price

$1,800,000
property

Leading Research BioTech Company

EBITDA

TBD

Gross

TBD

Price

TBA
property

Historical Pharma Manufacturing Business

EBITDA

$87,500,000

Gross

$306,500,000

Price

$1,050,000,000
property

40-Year-Old MENA Pharmaceutical Manufacturing Company

EBITDA

$6,279,944

Gross

$37,000,000

Price

$45,000,000
property

40 Year Old Pharmaceutical Manufacturing Business

EBITDA

$3,000,000

Gross

$25,000,000

Price

$40,000,000
property

20-Year Old Pharmaceutical South American Brand

EBITDA

$450,000

Gross

$2,000,000

Price

$11,500,000
property

40 Year Old Rx-pharma Manufacturing Business

EBITDA

TBA

Gross

$1,900,000

Price

$12,000,000

Pharma For Sale

Pharma Businesses for Sale, Find the Best Established Pharma Businesses for Sale, Pharma Businesses for Sale Marketplace, Buy a Pharma Business in, Pharma Companies for Sale, Discover opportunities for entrepreneurs in the United States, Pharma Companies for sale. Browse the Best Pharma Businesses for Sale Available to Buy Now, Pharma Business for Sale, Explore Pharma Business for Sale, Pharma Business for Sale, Pharma Business Opportunities.

Highly reputed testing lab with over a decade in operation. Specializes in pharmaceutical and beauty product development and testing, serving clients in the Northeast. Their comprehensive services include product development, formulation, stability testing, and long-term storage. With state- of-the-art equipment and a highly skilled team, this company excels in solving complex analytical problems, ensuring high- quality service and strong client relationships.

Investment Highlights

  • 2023: $1.5mn; $315k EBITDA, 21% margin
  • Strong revenue growth, achieving a YoY growth of 20%
  • Maintains a balanced revenue model, 40% of income from analytical services, 40% from development services, and 20% from storage services
  • Long-term contracts with core clients/ strategic partners drive 80% of revenue
  • Stellar experienced team willing to stay
  • Opportunities for growth include utilization of lab and equipment to full capacity (current utilization <50%), expansion into internation markets, strategic partnerships, and investment in marketing  strategy

MergersCorp M&A
International As Seen On

  • brand 1
  • brand 1
  • brand 1
  • brand 1
  • brand 1